|31.67||-0.86 / -2.64%|
As of 3:59pm ET
|31.67||0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for Anika Therapeutics Inc have a median target of 51.00, with a high estimate of 57.00 and a low estimate of 47.00. The median estimate represents a +61.04% increase from the last price of 31.67.
The current consensus among 4 polled investment analysts is to Buy stock in Anika Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.